Cannabis Bioscience International Holdings, Inc. (CBIH) stock
CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31
$0.00+0.00 (+33.33%)
Close on Oct 19, 2026Market cap $2.33MP/E –Yield –
Cannabis Bioscience International EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Cannabis Bioscience International's EPS for the twelve months ending Feb 28, 2026 was -$0.00. For fiscal 2025 it was -$0.00.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 31, 2025 | -$0.00 | – |
| FY2024 | May 31, 2024 | -$0.00 | – |
| FY2023 | May 31, 2023 | -$0.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -$0.00 | – |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -$0.00 | – |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -$0.00 | – |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $0.00 | – |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -$0.00 | – |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -$0.00 | – |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -$0.00 | – |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $0.00 | – |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -$0.00 | – |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $0.00 | – |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -$0.00 | – |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $0.00 | – |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -$0.00 | – |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -$0.00 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?